We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

8 hedge funds and large institutions have $1.77M invested in TriSalus Life Sciences Warrant in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

424% more capital invested

Capital invested by funds: $337K → $1.77M (+$1.43M)

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

100% more funds holding

Funds holding: 4 → 8 (+4)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
+4
Holders Change %
+100%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Cerity Partners
Cerity Partners
New York
+$1.05M
2
WAM
Wolverine Asset Management
Illinois
+$39.5K
3
AC
Aristeia Capital
Connecticut
+$35.8K
4
FBCM
Fort Baker Capital Management
California
+$33.7K
5
Bank of America
Bank of America
North Carolina
+$1.28K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$61.9K
2
ACM
Alpha Capital Management
Texas
-$18.7K

TLSIW Hedge Fund Activity: Q4 2025 in Review

8 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2025, worth a combined $1.77M — up 424% from $337K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TLSIW positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Cerity Partners, opening a new position worth an estimated $1.05M. The largest seller was Citadel Advisors, cutting an estimated $61.9K.

  • 8 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2025, up from 4 in Q3 2025.
  • Funds reported $1.77M of TriSalus Life Sciences Warrant stock for Q4 2025, up 424% quarter-over-quarter.
  • 5 funds opened new TriSalus Life Sciences Warrant positions in Q4 2025 and 1 closed out, a net change of +4 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q4 2025 was Cerity Partners, an estimated $1.05M added.
  • The largest TriSalus Life Sciences Warrant seller in Q4 2025 was Citadel Advisors, an estimated $61.9K sold.

Based on aggregated 13F filings for Q4 2025.